Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection

Feucht, 1991, Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection, Clin Exp Immunol, 86, 464, 10.1111/j.1365-2249.1991.tb02954.x Feucht, 1993, Capillary deposition of C4d complement fragment and early renal graft loss, Kidney Int, 43, 1333, 10.1038/ki.1993.187 Racusen, 2004, Banff 2003 meeting report: new diagnostic insights and standards, Am J Transplant, 4, 1562, 10.1111/j.1600-6143.2004.00585.x Racusen, 2003, Antibody-mediated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection, Am J Transplant, 3, 708, 10.1034/j.1600-6143.2003.00072.x Solez, 2007, Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'), Am J Transplant, 7, 518, 10.1111/j.1600-6143.2006.01688.x Feucht, 1996, The humoral immune response towards HLA class II determinants in renal transplantation, Kidney Int, 50, 1464, 10.1038/ki.1996.460 Murata, 2009, Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection, Transplant Rev (Orlando), 23, 139, 10.1016/j.trre.2009.02.005 Haas, 2014, Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, 14, 272, 10.1111/ajt.12590 Sis, 2010, Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection, Curr Opin Organ Transplant, 15, 42, 10.1097/MOT.0b013e3283352a50 Hidalgo, 2010, NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection, Am J Transplant, 10, 1812, 10.1111/j.1600-6143.2010.03201.x Sis, 2009, Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining, Am J Transplant, 9, 2312, 10.1111/j.1600-6143.2009.02761.x Park, 2003, Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury, Am J Transplant, 3, 952, 10.1034/j.1600-6143.2003.00179.x Haas, 2010, The significance of C4d staining with minimal histologic abnormalities, Curr Opin Organ Transplant, 15, 21, 10.1097/MOT.0b013e3283342ebd Haas, 2006, C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings, Am J Transplant, 6, 1829, 10.1111/j.1600-6143.2006.01356.x Baldwin, 2003, Complement in transplant rejection: diagnostic and mechanistic considerations, Springer Semin Immunopathol, 25, 181, 10.1007/s00281-003-0133-3 Loupy, 2017, The Banff 2015 Kidney Meeting Report: current challenges in rejection classification and prospects for adopting molecular pathology, Am J Transplant, 17, 28, 10.1111/ajt.14107 Haas, 2018, The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials, Am J Transplant, 18, 293, 10.1111/ajt.14625 Sigdel, 2018, Targeted transcriptional profiling of kidney transplant biopsies, Kidney Int Rep, 3, 722, 10.1016/j.ekir.2018.01.014 Sellares, 2013, Molecular diagnosis of antibody-mediated rejection in human kidney transplants, Am J Transplant, 13, 971, 10.1111/ajt.12150 Venner, 2015, The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors, Am J Transplant, 15, 1336, 10.1111/ajt.13115 Halloran, 2016, Molecular assessment of disease states in kidney transplant biopsy samples, Nat Rev Nephrol, 12, 534, 10.1038/nrneph.2016.85 Halloran, 2010, The molecular phenotype of kidney transplants, Am J Transplant, 10, 2215, 10.1111/j.1600-6143.2010.03267.x Halloran, 2013, Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM), Am J Transplant, 13, 2865, 10.1111/ajt.12465 Dominy, 2015, Use of quantitative real time polymerase chain reaction to assess gene transcripts associated with antibody-mediated rejection of kidney transplants, Transplantation, 99, 1981, 10.1097/TP.0000000000000621 Kikic, 2015, Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection, Clin J Am Soc Nephrol, 10, 1435, 10.2215/CJN.09901014 Mauiyyedi, 2002, Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification, J Am Soc Nephrol, 13, 779, 10.1681/ASN.V133779 Djamali, 2013, Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients, Kidney Int, 83, 1185, 10.1038/ki.2013.44 Haas, 2002, C4d staining of perioperative renal transplant biopsies, Transplantation, 74, 711, 10.1097/00007890-200209150-00021 Nickeleit, 2002, Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications, J Am Soc Nephrol, 13, 242, 10.1681/ASN.V131242 Dickenmann, 2006, The fate of C4d positive kidney allografts lacking histological signs of acute rejection, Clin Nephrol, 65, 173, 10.5414/CNP65173 Regele, 2002, Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection, J Am Soc Nephrol, 13, 2371, 10.1097/01.ASN.0000025780.03790.0F Mengel, 2005, Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial, Am J Transplant, 5, 1050, 10.1111/j.1600-6143.2005.00788.x Koo, 2004, C4d deposition in early renal allograft protocol biopsies, Transplantation, 78, 398, 10.1097/01.TP.0000128328.68106.54 Wasowska, 2010, Mechanisms involved in antibody- and complement-mediated allograft rejection, Immunol Res, 47, 25, 10.1007/s12026-009-8136-3 Ollert, 1994, Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps, J Immunol, 153, 2213, 10.4049/jimmunol.153.5.2213 Nishi, 2004, Pathological study on the relationship between C4d, CD59 and C5b-9 in acute renal allograft rejection, Clin Transplant, 18, 18, 10.1111/j.1399-0012.2004.00242 Sapir-Pichhadze, 2015, A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection, Kidney Int, 87, 182, 10.1038/ki.2014.166 Brocker, 2013, Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts, Nephrol Dial Transplant, 28, 3101, 10.1093/ndt/gft373 de Kort, 2015, The role of electron microscopy in renal allograft biopsy evaluation, Curr Opin Organ Transplant, 20, 333, 10.1097/MOT.0000000000000183